Dr. Michael Sefton is one of the pioneers of Tissue Engineering and is a co-founder of Rimon Therapeutics.  A Professor of Chemical Engineering and former Director of the Institute of Biomaterials and Biomedical Engineering at the University of Toronto, Dr. Sefton is a leader at the University and in the wider scientific community. A few years ago he was awarded the prestigious title of University Professor by the University of Toronto and last year he was named a Fellow of the Royal Society of Canada.

Dr. Sefton sits on the editorial boards of several prominent journals and has been on the grant selection committees for NSERC, MRC (now CIHR) and the US NIH. Dr. Sefton is the author of over 140 peer reviewed journal articles and is the recipient of many awards. For a complete bio see: http://www.rimontherapeutics.com

We had an opportunity to speak with Micheal Sefton at the Rimon Therapeutics’s office in late May about his career, Rimon Therapeutics, and the Biomaterials Sector in Canada. Here is what we discussed: